De Novo Urological Malignancies After Renal Transplantation: An Asian 30‐Year Experience
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Han Jie Lee, Ee Jean Lim, Shauna Jia Qian Woo, Edwin J. Aslim, Lay Guat Ng, Valerie Huei Li Gan |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease
por: Domitille Erard, et al.
Publicado: (2024)
por: Domitille Erard, et al.
Publicado: (2024)
Genetic and Functional Evaluation of the Complement System in De Novo Thrombotic Microangiopathy After Transplantation: A Single‐Center Experience
por: Adam Bregman, et al.
Publicado: (2025)
por: Adam Bregman, et al.
Publicado: (2025)
Solid Organ Malignancy After Pancreas Transplantation: A Four Decade Single‐Center Experience
por: Michael G. Megaly, et al.
Publicado: (2025)
por: Michael G. Megaly, et al.
Publicado: (2025)
Kidney Transplantation From Donors With Malignant Renal Masses: A Systematic Review
por: Vincenzo Villani, et al.
Publicado: (2024)
por: Vincenzo Villani, et al.
Publicado: (2024)
Outcomes of Heart Transplantation Based on Recipient’s Clinical Profile: 21-Year Experience
por: Margarita A. Peradejordi Lastras
Publicado: (2016)
por: Margarita A. Peradejordi Lastras
Publicado: (2016)
Correction to “Predictive Factors for Adverse Pregnancy Outcomes After Renal Transplantation”
Publicado: (2025)
Publicado: (2025)
Correction to “Risk Factors for Renal Dysfunction After Isolated Intestinal Transplantation”
Publicado: (2025)
Publicado: (2025)
Risk of Post‐Transplant Malignancy After Isolated Heart Transplant Among Adult Patients With Congenital Heart Disease
por: Orly Leiva, et al.
Publicado: (2025)
por: Orly Leiva, et al.
Publicado: (2025)
Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium
por: Paulo Lisboa Bittencourt, et al.
Publicado: (2024)
por: Paulo Lisboa Bittencourt, et al.
Publicado: (2024)
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)
Five‐Aminolevulinic Acid as a Potential Biomarker for Renal Insufficiency After Heart Transplantation
por: Xiao Huang, et al.
Publicado: (2025)
por: Xiao Huang, et al.
Publicado: (2025)
Liver Transplantation for Nijmegen Breakage Syndrome With Hepatic Malignancy and Hepatopulmonary Syndrome After Bone Marrow Transplantation: A Case Report
por: Oğuzhan Şal, et al.
Publicado: (2024)
por: Oğuzhan Şal, et al.
Publicado: (2024)
What Happens to Frailty in the First Year After Lung Transplantation?
por: Louise Mary Fuller, et al.
Publicado: (2024)
por: Louise Mary Fuller, et al.
Publicado: (2024)
Effect of Regional Anesthesia on Recovery Outcomes After Pediatric Renal Transplantation: A Retrospective Study
por: Lilinete Polsunas, et al.
Publicado: (2026)
por: Lilinete Polsunas, et al.
Publicado: (2026)
De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)
De Novo Psoriasis Following Belatacept Therapy in Transplant Recipients: Case Series
por: Grace Y. Im, et al.
Publicado: (2025)
por: Grace Y. Im, et al.
Publicado: (2025)
De Novo Onset of Myasthenia Gravis after Kidney Transplantation
por: Aaron de Souza, et al.
Publicado: (2024)
por: Aaron de Souza, et al.
Publicado: (2024)
Quality of Life in Patients 20–31 Years After Heart Transplantation
por: Wolfgang Albert, et al.
Publicado: (2024)
por: Wolfgang Albert, et al.
Publicado: (2024)
Intraoperative Cardiac Arrests in Asian Recipients of Liver Transplantation—Second Report After Learning Curve
por: Jisun Choi, et al.
Publicado: (2024)
por: Jisun Choi, et al.
Publicado: (2024)
Cardio‐Renal‐Metabolic Outcomes Associated With the Use of GLP‐1 Receptor Agonists After Heart Transplantation
por: Elena M. Donald, et al.
Publicado: (2024)
por: Elena M. Donald, et al.
Publicado: (2024)
Early‐Stage Endometrial Carcinoma After Renal Transplantation: Emphasizing Multidisciplinary Surgical Management
por: Akihiro Maeda, et al.
Publicado: (2026)
por: Akihiro Maeda, et al.
Publicado: (2026)
Medication Level Variability During First Year After Pediatric Kidney Transplantation
por: Lidan Gu, et al.
Publicado: (2026)
por: Lidan Gu, et al.
Publicado: (2026)
Liver Transplantation in Primary Hyperoxaluria: A Single‐Center 10‐Year Experience
por: Zahra Beyzaei, et al.
Publicado: (2025)
por: Zahra Beyzaei, et al.
Publicado: (2025)
Cardiovascular Risk in Pediatric Renal Transplant Recipients
por: Fernando Kazuaki Hamamoto, et al.
Publicado: (2024)
por: Fernando Kazuaki Hamamoto, et al.
Publicado: (2024)
Outcomes of Early Thrombotic Microangiopathy in Renal Transplantation
por: Girish K. Mour, et al.
Publicado: (2024)
por: Girish K. Mour, et al.
Publicado: (2024)
Adenovirus Disease Following Pediatric Liver Transplantation: 10‐Year Experience From a Large Pediatric Transplant Program
por: Anna M. Banc‐Husu, et al.
Publicado: (2026)
por: Anna M. Banc‐Husu, et al.
Publicado: (2026)
Pneumatosis Intestinalis and Pneumoperitoneum After Lung Transplantation: Single‐Center Experience and Systematic Review
por: Hiroshi Kagawa, et al.
Publicado: (2024)
por: Hiroshi Kagawa, et al.
Publicado: (2024)
Machine Learning for 1‐Year Graft Failure Prediction in Lung Transplant Recipients: The Korean Organ Transplantation Registry
por: Dasom Noh, et al.
Publicado: (2025)
por: Dasom Noh, et al.
Publicado: (2025)
Incidence and Management of Posttransplantation Lymphoproliferative Disorder After Pediatric Solid Organ Transplantation: The Norwegian Experience
por: Olav Sondre Skorge Aartun, et al.
Publicado: (2025)
por: Olav Sondre Skorge Aartun, et al.
Publicado: (2025)
Trends, Clinical Characteristics, and Outcomes of Percutaneous Coronary Intervention in Liver Transplant Recipients
por: Song Peng Ang, et al.
Publicado: (2025)
por: Song Peng Ang, et al.
Publicado: (2025)
Posttransplant Lymphoproliferative Disease Following Pancreas Transplantation: A 40 Year Single‐Center Experience
por: Abraham J. Matar, et al.
Publicado: (2024)
por: Abraham J. Matar, et al.
Publicado: (2024)
Association Between Early Immunosuppression Center Variability and One‐Year Outcomes After Pediatric Liver Transplant
por: Vikram K. Raghu, et al.
Publicado: (2025)
por: Vikram K. Raghu, et al.
Publicado: (2025)
Transplantation Related Mortality Did Not Show Significant Differences in Patients Aged Above 55 Years With Hematological Malignancies Receiving Allogeneic Hematopoietic Stem Cell Transplantation in a Real‐World Study
por: Jing Liu, et al.
Publicado: (2025)
por: Jing Liu, et al.
Publicado: (2025)
Successful Kidney Transplantation for Bilateral Renal Hypoplasia With Ebstein Disease
por: Sho Kimura, et al.
Publicado: (2024)
por: Sho Kimura, et al.
Publicado: (2024)
Meeting the Challenges of Post‐Transplant Lymphoproliferative Disorders After Liver Transplantation in Children: A Proposed Diagnostic and Management Algorithm
por: Nathalie Marie Rock, et al.
Publicado: (2025)
por: Nathalie Marie Rock, et al.
Publicado: (2025)
Fatigue, Sleep Problems, and Self‐Efficacy Before and After Heart Transplantation: A 5 Year Follow‐Up
por: Marita Dalvindt, et al.
Publicado: (2025)
por: Marita Dalvindt, et al.
Publicado: (2025)
Infectious Complications After Percutaneous Transhepatic Biliary Drainage in Pediatric Liver Transplant Recipients
por: Isaline Chabbey, et al.
Publicado: (2026)
por: Isaline Chabbey, et al.
Publicado: (2026)
Effects of Clean Intermittent Catheterization on Adherence in Pediatric Renal Transplant Patients
por: Sarah Ashley, et al.
Publicado: (2026)
por: Sarah Ashley, et al.
Publicado: (2026)
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
por: Marilyne Daher, et al.
Publicado: (2025)
por: Marilyne Daher, et al.
Publicado: (2025)
Transplantation of Horseshoe Kidneys: Surgical Strategies and 15‐Year Functional Outcomes From a Tertiary Center Experience
por: Francesco Nacchia, et al.
Publicado: (2026)
por: Francesco Nacchia, et al.
Publicado: (2026)
Ejemplares similares
-
Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease
por: Domitille Erard, et al.
Publicado: (2024) -
Genetic and Functional Evaluation of the Complement System in De Novo Thrombotic Microangiopathy After Transplantation: A Single‐Center Experience
por: Adam Bregman, et al.
Publicado: (2025) -
Solid Organ Malignancy After Pancreas Transplantation: A Four Decade Single‐Center Experience
por: Michael G. Megaly, et al.
Publicado: (2025) -
Kidney Transplantation From Donors With Malignant Renal Masses: A Systematic Review
por: Vincenzo Villani, et al.
Publicado: (2024) -
Outcomes of Heart Transplantation Based on Recipient’s Clinical Profile: 21-Year Experience
por: Margarita A. Peradejordi Lastras
Publicado: (2016)